NCT04935359 Study of Efficacy and Safety of NIS793 in Combination With Standard of Care (SOC) Chemotherapy in First-line Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC) - daNIS-2 Status COMPLETED Phase PHASE3
NCT04933552 Post-Authorization Safety Study for Assessment of Pregnancy Outcomes in Patients Treated With Mayzent Status RECRUITING Phase N/A
NCT04930094 Phase III Study of Efficacy and Safety of Secukinumab Versus Placebo, in Combination With Glucocorticoid Taper Regimen, in Patients With Giant Cell Arteritis (GCA) Status COMPLETED Phase PHASE3
NCT04929249 A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTORION-INITIATE) Status COMPLETED Phase PHASE3
NCT04926818 Efficacy and Safety of Ofatumumab and Siponimod Compared to Fingolimod in Pediatric Patients With Multiple Sclerosis Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04925479 Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia Status RECRUITING Phase PHASE1/PHASE2
NCT04905316 A Study of Canakinumab With Chemotherapy, Radiation Therapy, and Durvalumab in People With Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT04903613 Global Managed Access Program Cohort for Ligelizumab in CSU Status NO_LONGER_AVAILABLE Phase N/A
NCT04903197 Study of VAY736 as Single Agent and in Combination With Select Antineoplastic Agents in Patients With Non-Hodgkin Lymphoma Status TERMINATED Phase PHASE1
NCT04899349 Study of Safety and Efficacy of Dapagliflozin + Metformin XR Versus Metformin XR in Participants With HR+, HER2-, Advanced Breast Cancer While on Treatment With Alpelisib and Fulvestrant Status TERMINATED Phase PHASE2
NCT04896632 Study of Safety, Tolerability, and Pharmacokinetics of INE963 in Healthy Participants Status TERMINATED Phase PHASE1
NCT04895748 DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies Status TERMINATED Phase PHASE1
NCT04895202 Swiss Study of the Impact of Mayzent on SPMS Patients in a Long-term Non-interventional Study Status TERMINATED Phase N/A
NCT04894890 A Prospective Multicenter Study for the Assessment of Treatment Patterns, Effectiveness and Safety of Secukinumab in Adult Patients With Moderate to Severe Plaque Psoriasis in a Real-world Setting in China Status COMPLETED Phase N/A
NCT04889430 Efficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy Status COMPLETED Phase PHASE3
NCT04886258 Study of Efficacy, Safety and Tolerability of DFV890 in Patients With Knee Osteoarthritis Status COMPLETED Phase PHASE2
NCT04883528 Protecting With ARNI Against Cardiac Consequences of Coronavirus Disease 2019 Status COMPLETED Phase PHASE1/PHASE2
NCT04882124 Study of Effect of CSJ117 on Symptoms, Pharmacodynamics and Safety in Patients With COPD Status COMPLETED Phase PHASE2